Joseph’s Well Releases 2025 Update on Faith-Based Water Security Innovation Amid Rising Drought and Global Instability

PHOENIX, July 01, 2025 (GLOBE NEWSWIRE) — Section 1 – Introduction Across the United States, signs of a growing water crisis are becoming impossible to ignore. From drying reservoirs and collapsing aquifers to multi-year drought patterns now classified as “megadroughts,” researchers and citizens alike are waking up to a dangerous truth: the water systems Americans […]

Joseph’s Well Releases 2025 Update on Faith-Based Water Security Innovation Amid Rising Drought and Global Instability

Joseph's Well Releases 2025 Update on Faith-Based Water Security Innovation Amid Rising Drought and Global Instability In this 2025 preparedness update, Joseph's Well shares timely insights on atmospheric water generation technology designed for off-grid use. With intensifying megadrought forecasts and increasing global uncertainty, the announcement highlights how a biblical approach to water independence–rooted in personal

KIA AMERICA ANNOUNCES 2026 SPORTAGE PHEV PRICING

— 2026Kia Sportage PHEV pricing starts at $40,4901 — Refreshed X-Line and X-Line Prestige models blend comfort and power — “Opposites United” design philosophy takes on a more confident and refined style withKia's LED star map lighting and distinctive amber DRLs — New X-Line trim now available in 1.6T Plug-in Hybrid Today, Kia America announced

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Esse Health Customers Whose Data May Have Been Compromised

The law firm of Edelson Lechtzin LLP, based in suburban Philadelphia, is investigating data privacy claims regarding an incident at Esse Health. Esse Health learned of a data breach on or about April 21, 2025. https://mma.prnewswire.com/media/2457789/logo2_Logo.jpg If you have received a notice concerning the Esse Health data breach and would like to speak with a

SRPT INVESTOR NOTICE: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sarepta Therapeutics, Inc. (NASDAQ; SRPT) securities between June 22, 2023 and June 24, 2025, both dates inclusive (the “Class Period”), have until August 25, 2025 to seek appointment as lead plaintiff of the Sarepta class action lawsuit. Captioned Dolgicer v. Sarepta Therapeutics, Inc.,

KBR, Inc. (KBR) Shares Sharply Declined Amid TRANSCOM Contract Termination- Hagens Berman

(NYSE:KBR), SAN FRANCISCO, July 01, 2025 (GLOBE NEWSWIRE) — On June 20, 2025 investors in KBR, Inc. (NYSE: KBR) saw the price of their shares decline over 7% after the company announced that the Department of Defense U.S. Transportation Command (“TRANSCOM”) cancelled its global household goods contract (“contract”) awarded to HomeSafe Alliance LLC, a KBR

KBR, Inc. (KBR) Shares Sharply Declined Amid TRANSCOM Contract Termination- Hagens Berman

KBR, Inc. (KBR) Shares Sharply Declined Amid TRANSCOM Contract Termination- Hagens Berman GlobeNewswire July 01, 2025 SAN FRANCISCO, July 01, 2025 (GLOBE NEWSWIRE) — On June 20, 2025 investors in KBR, Inc. (NYSE: KBR) saw the price of their shares decline over 7% after the company announced that the Department of Defense U.S. Transportation Command

iconPCR™: Powering the Next Wave of Metagenomics and Microbiome Discovery

How a New Approach to PCR is Transforming Microbial Research The landscape ofmetagenomics and microbiome research is evolving at breakneck speed. As sequencing technologies improve and the demand for high-resolution, bias-free microbial data grows, the bottleneck is shifting from sequencing itself to the quality of upstream sample preparation. At the heart of this transformation is

FDA Expands Indications for Neuraceq®, an Amyloid PET Imaging Agent, to Enhance Diagnosis and Care of Patients with Alzheimer’s Disease

New indication added for selection of patients for amyloid-directed therapiesQuantitative image analysis addedPrevious limitations of use removed Life Molecular Imaging, Ltd. (LMI) announced that the U.S. Food and Drug Administration (FDA) has approved updated labeling for Neuraceq® (florbetaben F18 injection), expanding its indication for selecting patients for amyloid-targeting therapies, as described in the prescribing information

Labubu Mania Finds New Home on Palmstreet Live Auctions, Launching 31 Days of Daily Giveaways

Live Shopping App Palmstreet Launches Collectibles Market with Coveted Labubu Resellers and Daily Prize Campaign Palmstreet, the live shopping app for rare plants, crafts, and unique goods, officially debuts its collectibles category today for sought-after toys, trading cards, and pop culture items. The launch comes just in time for the viral demand of Pop Mart's

Scroll to Top